ask Ask a question
Favorite

Size exclusion chromatography (SEC)-HPLC analysis was performed based on previously reported [22]. Each ADCs was analyzed AdvanceBio SEC 300 Å, 4.6 × 150 mm, 2.7 µm column (Agilent), (Tosoh Bioscientific), connected to an Agilent 1260 HPLC system containing a binary gradient pump, a temperature-controlled column compartment, an autosampler, and a diode array detector. The system conditions were as follows: flow rate = 0.25 mL/min at 30 °C; mobile phase A (MPA) = 100 mM NaHPO4/NaH2PO4, 250 mM NaCl, 10% v/v IPA, pH 6.8 (mobile phase, MP). The absorbance was monitored at 280 nm (reference wavelength at 450 nm). Each ADC (1 mg/mL, 40 μL) was injected into the system and eluted over an 11 min run consisting of MP.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A